PRC
BDSI

Pearl River Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Pearl River Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,128
Closed -$115K – 796
2019
Q4 		$115K Buy
+18,128
New +$107K 0.04% 504

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pearl River Capital's BDSI Position: Q1 2020 in Review

Pearl River Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 18,128 shares — an estimated $115K sold.

Pearl River Capital first reported a position in BDSI in Q4 2019 and held it in 1 quarter. The position peaked at $115K in Q4 2019. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.

  • Pearl River Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
  • Pearl River Capital sold 18,128 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $115K.
  • Pearl River Capital first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 1 quarter.
  • Pearl River Capital's BioDelivery Sciences International, Inc. position peaked at $115K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.

Based on Pearl River Capital's 13F filing for Q1 2020, filed 6 May 2020.